Improved transient silencing of gene expression in the mosquito female Aedes aegypti by McFarlane, Melanie et al.
Improved transient silencing of gene expression in the
mosquito female Aedes aegypti
M. McFarlane*, M. Laureti*a, T. Levée*, S. Terry*,
A. Kohl* and E. Pondeville*
*MRC-University of Glasgow Centre for Virus Research,
Glasgow, UK
Abstract
Gene silencing using RNA interference (RNAi) has
become a widely used genetic technique to study gene
function in many organisms. In insects, this technique
is often applied through the delivery of dsRNA. In the
adult female Aedes aegypti, a main vector of human-
infecting arboviruses, efficiency of gene silencing
following dsRNA injection varies greatly according to
targeted genes. Difficult knockdowns using dsRNA
can thus hamper gene function analysis. Here, by ana-
lysing silencing of three different genes in female
Ae. aegypti (p400, ago2 and E75), we show that gene
silencing can indeed be dsRNA sequence dependent
but different efficiencies do not correlate with dsRNA
length. Our findings suggest that silencing is likely also
gene dependent, probably due to gene-specific tissue
expression and/or feedback mechanisms. We demon-
strate that use of high doses of dsRNA can improve
knockdown efficiency, and injection of a transfection
reagent along with dsRNA reduces the variability in effi-
ciency between replicates. Finally, we show that gene
silencing cannot be achieved using siRNA injection in
Ae. aegypti adult females. Overall, this work should help
future gene function analyses using RNAi in adult
females Ae. aegypti, leading toward a better under-
standing of physiological and infectious processes.
Keywords: gene silencing, dsRNA, siRNA, RNA inter-
ference, Aedes aegypti.
1. Introduction
Mosquito-borne arboviruses cause a large medical, veteri-
nary and economic impact on predominately tropical and
sub-tropical regions of the world. Medically important
mosquito-borne arboviruses include chikungunya, den-
gue, Zika and yellow fever virus (Weaver and
Reisen, 2010; Weaver et al., 2016; Mayer et al., 2017;
Wilder-Smith et al., 2017; Paixao et al., 2018). The major
vector for these viruses is the Aedes aegypti (Ae. aegypti)
mosquito. Despite the huge burden these viruses cause to
the healthcare systems and the economy in endemic coun-
tries there are few effective vaccines or antivirals available
to target infections caused by these viruses. Therefore,
mosquito control remains a key strategy to limit arbovirus
transmission (Kean et al., 2015; Achee et al., 2019; Lam-
brechts and Saleh, 2019). As Aedes mosquitoes develop
resistance to insecticides (Dusfour et al., 2019), new vector
control strategies are urgently needed. Therefore, it is
important to increase our understanding of mosquito biol-
ogy and mosquito-arbovirus interactions that influence
the outcome of arbovirus infection in mosquitoes. The
major advances in the last two decades in vector biology,
genomics/comparative genomics, transcriptomics and pro-
teomics have allowed the identification of a large number of
genes and proteins putatively involved in mosquito-
arbovirus interactions. However, the functions of many of
them are still unknown.
In a model and genetically transformable species, such
as Drosophila melanogaster, reverse functional genomics
(from gene to phenotype) is classically achieved using
mutant lines or RNA interference (RNAi). In the latter case,
animals are genetically transformed to contain a transgene
in their genome expressing a gene fragment cloned as an
inverted repeat. This results in the expression of a hairpin
double-stranded RNA (dsRNA), which is recognized by
the small interfering RNA (siRNA) pathway. Upon recogni-
tion, the nuclease Dicer-2 (Dcr2) chops the hairpin dsRNA
into short interfering RNA duplexes (siRNAs). These smal-
ler fragments are then loaded into a multi-protein complex
called the RNA Induced Silencing Complex (RISC) where
the active component Argonaute-2 (Ago2) binds to the
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siRNA and unwinds and degrades one of the strands. The
remaining strand is used to target homologous mRNAs for
degradation and thus gene silencing. This system can be
combined with the GAL4-UAS system to drive the expres-
sion of such hairpin dsRNA, and therefore analyse gene
function, in a stage- and tissue-specific manner (Dietzl
et al., 2007; Belles, 2010).
Although good progress has been made in the last
decade with mosquito transformation techniques
(Nimmo et al., 2006; Meredith et al., 2011; Pondeville
et al., 2014; Kistler et al., 2015; Li et al., 2017; Chaverra-
Rodriguez et al., 2018), very few mosquito genetic tools
and transgenic lines have been produced, in comparison
to model organisms. In addition, establishment of mos-
quito transgenic lines requires specific equipment and
reagents, skills and training, is time- and space-consum-
ing, and is greatly hampered by the small number of well
characterized tissue-specific promoters and the absence
of tools to maintain toxic/lethal mutants and transgenes.
For these reasons, the easiest method so far to study
gene function without having to generate genetically mod-
ifiedmosquito lines, is through transient gene silencing by
directly delivering in vitro-synthetized dsRNA into mos-
quitoes at the stage of interest and then analysing the
resulting phenotype.
Transient RNAi in adult mosquitoes was first performed
in Anopheles gambiae to knockdown the defensin gene
in adult females (Blandin et al., 2002). In this species, tran-
sient gene silencing in adults has proved successful to
knockdown genes in multiple tissues and cells involved in
parasite development, including midgut, haemocytes and
ovaries by injecting into the haemolymph 100–150 ng of
dsRNA (Blandin et al., 2002; Osta et al., 2004; Boisson
et al., 2006). However, RNAi efficiency can greatly vary
between species, with some insect species requiring high
doses of dsRNA to efficiently silence genes (Belles, 2010;
Joga et al., 2016). Even in sensitive species, knockdown
efficiency is tissue- and dose-dependent. For example,
Boisson et al. showed that silencing gene expression in
salivary glands and the muscle cells surrounding the mid-
gut in An. gambiae requires high concentrations of dsRNA
(Boisson et al., 2006). InAe. aegypti, knockdown efficiency
following injection of 200–500 ng of dsRNA seems to vary
according to genes with some genes silenced quite effi-
ciently (up to 80%) and other genes for which knockdown
efficiency is relatively low (0–20%) (Sim et al., 2013;
McFarlane et al., 2014; Anglero-Rodriguez et al., 2017;
Barletta et al., 2017). Recently, we identified p400 as a pos-
itive regulator of the antiviral exogenous siRNA pathway
and restricting factor of arbovirus infection in Ae. aegypti
(McFarlane et al., 2020). Using classical doses (i.e.
500 ng per female) of dsRNA targeting p400, we were
unable to achieve a sufficient and reproducible silencing
efficiency. Therefore, we sought to optimize and determine
a transient silencing protocol to facilitate successful and
reproducible knockdown in Ae. aegypti mosquitoes.
Our findings presented here confirm that silencing effi-
ciency is indeed gene dependent. The ability of the dsRNA
to produce a significant knockdown was not due to the tar-
get functioning as part of the siRNA pathway itself or to the
length of the dsRNA but is likely gene- and sequence-
dependent. We show that different dsRNA sequences for
a single target gene can lead to different knockdown effi-
ciencies. However, some genes are more difficult to
silence independently of the dsRNA sequence. For those
genes, we show that increasing the injected dsRNA quan-
tity can improve gene silencing. Importantly, including a
transfection reagent increases the reproducibility of silenc-
ing levels across replicates and thereby enhances the
quality of experiments, without adversely affecting the sur-
vival of themosquitoes. Finally, we show that while delivery
of siRNA can be used to efficiently knockdown genes in
cultured mosquito cells, injection of siRNA in adult females
did not result in target gene silencing. Overall, our results
indicate that in Ae. aegypti females the sequence of the
dsRNA and nature of the target mRNA are the major deter-
minants of a successful knockdown, and that for genes
whose expression is not significantly affected by classical
dsRNA doses, silencing can be improved by injecting
higher amount of dsRNA and transfection reagent
together.
2. Results
2.1 Effect of two different transfection reagents on
mosquito survival and knockdown efficiency
A previous study showed that cationic liposomes can
increase delivery and expression of plasmid DNA in Ae.
aegypti and An. gambiae mosquitoes (Cheng
et al., 2011). We therefore hypothesized that injecting
dsRNA along with a cationic liposome could also enhance
cellular delivery of dsRNA, and thereby could increase
knock down efficiency in Ae. aegypti adult females. To test
this hypothesis, mosquito females were injected with 2 μg
of dsRNA targeting p400 (dsp400-1) or ß-galactosidase
gene (dsLacZ, control) with a cationic-lipid transfection
reagent or without (same final volume injected, adjusted
with S2media). As transfection reagents can have different
efficiencies in different cell lines and some have deleteri-
ous effects on mosquito survival (Cheng et al., 2011), two
different reagents were tested, Cellfectin II and Dharma-
FECT2. Mosquito survival was monitored for three days
post injection (dpi) and knock down efficiency was
assessed in females at four dpi, a time at which gene
silencing by dsRNA can generally be observed (Blandin
et al., 2002; Boisson et al., 2006). Injection of dsRNA with
Cellfectin II did not influence mosquito survival while injec-
tion of dsRNA with DharmaFECT2 resulted in a 10%
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reduction compared to injection with Cellfectin II or without
transfection reagent, although this was not significant
(Fig. 1A). While p400 knockdown was detectable with
transfection reagent or without, inclusion of Cellfectin II
led to a greater knockdown efficiency and reduced the var-
iability (Fig. 1B). Taken together, these data indicate that
Cellfectin II aids knockdown and reproducibility without
affecting mosquito survival. Therefore, Cellfectin II was
selected for further experiments.
2.2 dsRNA injection with Cellfectin II improves
knockdown efficiency
To test whether the addition of Cellfectin II could allow a
reduction of the dsRNA quantity needed to knockdown
p400, female mosquitoes were injected with varying
quantities of dsp400-1 or dsLacZ (500 ng, 1 μg and 2 μg)
in the presence or absence of transfection reagent and
silencing was determined by RT-qPCR at four dpi. Consis-
tent with previous results, when 2 μg of dsRNA was
injected, the inclusion of Cellfectin II improved the knock-
down efficiency of p400 and reduced the variability across
replicates (Fig. 2A). However, the addition of the transfec-
tion reagent did not improve knockdown efficiency of the
lower quantities (1 μg and 500 ng) of dsRNA injected
(Fig. 2A). The length of dsRNA has been shown to influ-
ence the efficacy of the RNAi with longer dsRNA being
more effective to knockdown gene expression (Miller
et al., 2012). To ensure that the difficulty in achieving a sig-
nificant knockdown of p400 was not due to the short size of
the dsRNA (dsp400-1 is 149 bp in length), we designed a
longer dsRNA targeting p400 mRNA (dsp400-2, 317 bp;
Figure 1. Test of different transfection reagents on mosquito survival and knock down efficiency. Female mosquitoes were injected with 2 μg dsRNA targeting
p400 (dsp400) or LacZ (dsLacZ, control) and with different transfection reagents, Cellfectin II and DharmaFECT, or without (same volume injected, adjustedwith
S2 media). (A) Mosquito survival for 4 days post dsRNA injection. Female mosquitoes injected with the same transfection reagent but different dsRNAs were
pooled together to assess survival linked to transfection reagent. Survival was not significantly different using a Log-rank Mantel-Cox test. (B) Relative p400
expression knockdown efficiency was assessed in female mosquitoes injected with either Cellfectin, Dharmafect, or without transfection reagent, and compared
to dsLacZ 4 days post injection by RT-qPCR. Results were analysed as previously described (Taylor et al., 2019). The group geomean of control LacZwas set to
1 and the geomean of p400 calculated relative to LacZ. Error bars show the RQmin and RQmax (n = 3 biological replicates; 10 females pooled per condition and
replicate). Percentages show the reduction in transcript expression. Significance was determined by an unpaired student’s t-test.
Figure 2. Optimization of p400 knockdown. Various quantities of dsRNA targeting p400 was injected into female mosquitoes in the presence or absence of
Cellfectin II. Knockdown efficiency was determined by RT-qPCR 4 days post injection and results analysed by the method outlined by Taylor et al. 2019 (Taylor
et al., 2019). The group geomean of control LacZ was set to 1 and the geomean of p400 calculated relative to LacZ. Error bars show the RQ min and RQ max
(n = 3 biological replicates; 10 females pooled per condition and replicate). Percentages show the reduction in transcript expression. Significance was
determined by an unpaired student’s t-test. Two different dsRNAs were tested (A) a short version and (B) longer version of dsRNA.
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dsRNA used in (McFarlane et al., 2020); Fig. 2B). Again,
the presence of Cellfectin II increased the efficiency of
knockdown and its reproducibility, however, a high quantity
of dsRNA was still required to achieve a detectable
knockdown.
2.3 Silencing efficiency is gene and sequence
dependent
We previously showed that p400 is a positive regulator of
the siRNA pathway in Ae. aegypti (McFarlane
et al., 2020). As gene knockdown relies on the siRNA path-
way activity, we therefore wondered whether the difficulty
in knocking down p400 was related to its role in the siRNA
pathway function. To investigate this, dsRNA targeting two
other genes were tested. A dsRNA targeting ago2, which is
a critical effector of the exogenous siRNA pathway (Donald
et al., 2012; Blair and Olson, 2015; Samuel et al., 2018), as
well as a dsRNA targeting E75, a gene that does not have a
role in the siRNA pathway but which is a nuclear receptor
involved in the steroid response during reproduction in
Ae. aegypti (Cruz et al., 2012). These dsRNA were
designed to have roughly the same size as dsp400-1
(143 bp for dsago2 and 130 bp for dsE75-1) to exclude
any size effect. Different quantities (2 μg, 1 μg and
500 ng) of dsRNA targeting ago2 were injected into adult
femalemosquitoes in the presence or absence of Cellfectin
II and silencing measured four dpi by RT-qPCR (Fig. 3A).
The expression of ago2 was successfully knocked down
with all concentrations we tested irrespective of whether
Cellfectin II was included in the injection mix. In contrast
to ago2, a very low knockdown of E75 expression was
obtained with dsE75-1 irrespective of the addition of Cell-
fectin II and dsRNA quantities injected, although Cellfectin
II did reduce variability between experiments (Fig. 3B) as
observed for p400. We next tested a second dsRNA
sequence targeting another region of E75 (dsE75-2,
108 bp). Using this dsRNA, knock down efficiency was
improved (Fig. 3C). Inclusion of Cellfectin II did not
enhance knockdown, however, it reduced variability
between experiments.
Figure 3. Optimisation of ago2 and E75 knockdown. (A) Various quantities of dsRNA targeting ago2 was injected into female mosquitoes in the presence or
absence of Cellfectin II. Knockdown efficiency was determined by RT-qPCR 4 days post injection and results analysed as previously described (Taylor
et al., 2019). The group geomean of control LacZ was set to 1 and the geomean of ago2 calculated relative to LacZ. Error bars show the RQ min and RQ max
(n = 3 biological replicates; 10 females pooled per condition and replicate). Percentages show the reduction in transcript expression. Significance was
determined by an unpaired student’s t-test (*P = <0.05; **P = <0.001). (B) and (C) Various concentrations of two different dsRNAs targeting E75 were injected
into female mosquitoes in the presence or absence of Cellfectin II. Knockdown efficiency was determined by RT-qPCR 4 days post injection and results
analysed as previously described (Taylor et al., 2019). The group geomean of control LacZ was set to 1 and the geomean of E75 calculated relative to LacZ.
Error bars show the RQ min and RQ max (n = 3 biological replicates; 10 females pooled per condition and replicate). Percentages show the reduction in
transcript expression. Significance was determined by an unpaired student’s t-test (*P = <0.05; **P = <0.001; ***P = <0.0001).
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As these are high concentrations of dsRNA, we wanted
to test silencing efficiency using a reduced concentration
of dsRNA. As ago2 silencing was highly efficient we
reduced the concentration tested in the presence or
absence of Cellfectin II (Fig. 4). Female mosquitoes were
injected with 100 ng, 200 ng or 300 ng of dsRNA with or
without transfection reagent and silencing determined four
dpi by RT-qPCR. Reduced quantities of dsRNA targeting
ago2 still resulted in a highly significant knockdown in
ago2mRNA levels, although the percentage of knockdown
was lower compared to experiments with 500 ng to 2 μg
(Fig. 3A). Altogether, the results of these experiments indi-
cate that for genes that are difficult to knockdown:
(1) increasing the quantity of dsRNA improves silencing,
(2) addition of a transfection reagent enhances silencing
efficiency by reducing variation between independent rep-
licates and (3) that design of the dsRNA has a greater
impact on the effectiveness of the dsRNA than the function
of the targeted mRNA.
2.4 siRNA can knockdown expression in vitro but not
in vivo in Ae. aegypti
Due to the time-consuming nature of production of dsRNA
and the possibility of generating “off targets” (Kulkarni
et al., 2006), we sought to characterize the silencing activ-
ity of siRNAs in vivo. We first wanted to determine the best
purification method for siRNA production, for standard or
in vivo applications. To test this, we purchased LacZ-
targeting siRNAs synthesised and purified either by the
standard or in vivo purification protocol. siRNAs resus-
pended in PBS or PBS alone as control were injected into
females (2 μg per female) and survival monitored for three
days. Although the injection of siRNAs purified for in vivo
application resulted in a slightly better survival compared
to injection of siRNAs purified for standard application, this
was not significant (Fig. S1A). Considering the higher cost
of siRNAs purified for in vivo applications compared to
standard applications, standard purification was therefore
chosen for further experiments. We then wanted to ensure
that the resuspension solution we used did not adversely
affect mosquito survival. PBS is more commonly used for
in vivo experiments compared to water, however, resus-
pension of the siRNAs in water allowed us to determine
the concentration of the siRNAs to ensure precise and
reproducible calculations for our injection mix. We there-
fore injected adult female mosquitoes with either PBS or
water andmonitored their survival (Fig. S1B). No difference
in survival was detected between conditions, therefore,
siRNA resuspension with water was chosen.
Next, we sought to confirm that siRNAs could knock-
down transcripts in vivo. For this we used siRNA
sequences that were previously published (Varjak
et al., 2017). We first confirmed that the siRNAs could func-
tion in vitro in our hands. Ae. aegypti-derived Aag2 cells
were transfected with ago2- or control LacZ-targeting siR-
NAs. One day post transfection, cells were lysed and
RNA extracted. The level of gene silencingwas determined
by RT-qPCR. As expected, transfection of ago2 siRNAs
resulted in a 73% knockdown of ago2 transcript expression
(Fig. 5A). As the siRNAs were designed based on the ago2
sequence deposited on VectorBase, we next confirmed the
ago2 siRNA sequence targeted the ago2 transcript present
in our Ae. aegypti Liverpool strain mosquitoes. As the siR-
NAs worked well in vitro and the sequence matched our
mosquito colony, we then went on to test the siRNAs
in vivo. Female mosquitoes were injected with 2 μg of
ago2- or control LacZ- targeting siRNAs or dsRNAs along
with Cellfectin II transfection reagent. Four dpi, mosquitoes
were lysed in TRIzol and RNA extracted. Gene expression
was determined by RT-qPCR. While the expression of
ago2 was successfully knocked down using dsRNAs, the
siRNAs did not silence expression of ago2 in vivo
(Fig. 5B). We also confirmed that siRNAs did not silence
ago2 expression in vivo in the presence of DharmaFECT2
(data not shown).
3. Discussion
Together with genome sequencing, the advent of RNAi
opened the door to loss-of-function analyses in many
non-model insects for which genetic transformation was
Figure 4. Further optimization of ago2 silencing. Reduced concentrations of
dsRNA targeting ago2 were injected into female mosquitoes in the
presence or absence of Cellfectin II. Knockdown efficiency was determined
by RT-qPCR 4 days post injection and results analysed as previously
described (Taylor et al., 2019). The group geomean of control LacZ was set
to 1 and the geomean of ago2 calculated relative to LacZ. Error bars show
the RQ min and RQ max (n = 3 biological replicates; 10 females pooled per
condition and replicate). Percentages show the reduction in transcript
expression. Significance was determined by an unpaired student’s t-test
(*P = <0.05; **P = <0.001; ***P = <0.0001; ****P < 0.00001).
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not possible or could not be routinely achieved
(Belles, 2010; Mito et al., 2011). In the last two decades,
transient gene silencing has been instrumental to identify
many factors involved in mosquito-pathogen interactions
such as immune pathways. While transient gene silencing
to study gene function in Ae. aegypti mosquitoes still
remains easier and faster to perform than genome editing,
some genes appear to be more difficult to knockdown than
others, and this can hamper phenotype analysis. Here we
have shown that for some genes that are difficult to silence
using classical doses of dsRNA, increasing the injected
quantity of dsRNA up to 2 μg per female can improve
silencing efficiency. Addition of a cationic lipid transfection
reagent does not necessarily enhance knockdown but
does improve the efficiency by reducing the variation
between replicates. Importantly, inclusion of the transfec-
tion reagent, here Cellfectin II, did not significantly reduce
mosquito survival. There was, however, a small reduction
in survival when another transfection reagent, Dharma-
FECT 2, was included. This reduction was not significant
and would not have prevented the inclusion of this reagent
in transfection mixes if it had performed better in knock-
down studies. As injection of some transfection reagents,
such as FuGENE6, can be lethal for Ae. aegypti mosqui-
toes (Cheng et al., 2011), this shows that reagents should
be tested before use, to ensure a beneficial impact which
is not negated by any small reduction in mosquito survival.
Our results show that the difficulty to knock down p400
was likely not due to its involvement in the siRNA pathway,
which is exploited to silence genes. Indeed, targeting of
another RNAi pathway component, ago2, resulted in signif-
icant knockdown with relatively small dsRNA quantities
(down to 100 ng), consistent with previous studies using
dsRNA targeting ago2 and dcr2 in Ae. aegypti and An.
gambiae (McFarlane et al., 2014; Carissimo et al., 2015).
A non-RNAi pathway-related gene, E75, was also difficult
to knockdown confirming that gene involvement in the
siRNA pathway is not a determining factor in its silencing
efficiency. siRNA produced from dsRNA sequences can
have different efficiencies (Horn and Boutros, 2010). Differ-
ent dsRNA sequences designed using E-RNAi (Horn and
Boutros, 2010) were tested for p400 (three sequences,
one not shown) and E75 (two sequences). We could
improve efficiency for E75 silencing (using dsE75-2 com-
pared to dsE75-1), showing that knockdown efficiency
can be sequence dependent. The predicted number of effi-
cient siRNAs that can be produced from the dsRNAs
(104 for dsE75-1 and 90 for dsE75-2) cannot explain a bet-
ter efficiency of dsE75-2. However, as E-RNAi uses score
methods developed from studies in human cells, it cannot
be excluded that there are differences in the parameters
influencing siRNA efficiency between organisms. Alterna-
tively, the dsRNA structure could affect Dcr2 specificity
and efficiency resulting in different siRNA production yields
(Vermeulen et al., 2005). Since we did not sequence small
RNAs produced in injected mosquitoes, it is not possible to
know if dsE75-2 gives rise to more siRNAs or more potent
siRNAs compared to dsE75-1.
It is likely that difficulty in knocking down some genes is
not only linked to the dsRNA sequence as even using dif-
ferent sequences, knockdown efficiency could not be
greatly improved. Different factors have been previously
identified or hypothesized to affect RNAi efficiency in insect
species, such as the presence of nucleases, the length and
concentration of dsRNA, and dsRNA uptake (Belles, 2010;
Joga et al., 2016). The presence of dsRNAses in the hae-
molymph can decrease silencing efficiency and explain
the RNAi insensitivity of some insect species (Garbutt
et al., 2013; Shukla et al., 2016; Wang et al., 2016). How-
ever, considering that some genes, such as ago2 in this
Figure 5. Testing of siRNA-induced silencing. (A) Aag2 cells were transfected with LacZ- or ago2-targeting siRNAs and the level of silencing determined after
24 h. Knockdown was determined by RT-qPCR and results analysed by the method outlined by Taylor et al. 2019 (Taylor et al., 2019). The group geomean of
control LacZ was set to 1 and the geomean of ago2 calculated relative to LacZ. Error bars show the RQ min and RQ max (n = 4 biological replicates; 3 wells
pooled per condition and replicate). Percentages show the reduction in transcript expression. Significance was determined by an unpaired student’s t-test
(*P = <0.05). (B) Female mosquitoes were injected with either siRNA or dsRNA targeting ago2 or control LacZ. Silencing was measured 4 days post injection.
Silencing was determined by RT-qPCR and results were analysed as previously described (Taylor et al., 2019). The group geomean of control LacZ was set to
1 and the geomean of ago2 calculated relative to LacZ. Error bars show theRQmin and RQmax (n = 3 biological replicates; 10 females pooled per condition and
replicate). Percentages show the reduction in transcript expression. Significance was determined by an unpaired student’s t-test (**P = <0.001).
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study, can be silenced using low quantities of dsRNA, it
seems unlikely that some dsRNAses highly degrade
dsRNA in the haemolymph in Ae. aegypti adult females.
The length of the dsRNAwas also reported to be a potential
determinant of whether a dsRNA functions efficiently
(Miller et al., 2012; Joga et al., 2016). Although there had
been few studies looking at the dsRNA length requirement
in insects, design of long dsRNAs (between 100 and
700 bp) is generally preferred as this increases the proba-
bility of producing efficient siRNAs generated by Dcr2.
However, longer dsRNA could potentially lead to more off
target effects and therefore false phenotypic effects (Kulk-
arni et al., 2006). It has been shown that shorter dsRNA
are more easily taken up into cells than longer strands,
however, this does not mean that the RNAi pathway is effi-
ciently activated, in contrast, it was reported that longer
dsRNA provided a stronger and more prolonged activation
of the RNAi response in Tribolium castaneum (Miller
et al., 2012). The length of dsRNA was not found to be
important for the silencing efficiency in this study. Indeed,
a similar p400 silencing rate was obtained using dsRNA
of different sizes (149 and 317 bp) and using dsRNA of
roughly the same size to target p400 (149 bp) and ago2
(143 bp), respectively, led to different gene silencing
efficiencies.
The difference between gene knockdown efficiency
could instead be due to differences in tissue-specific
expression of targeted genes. Indeed, RNAi can be ineffi-
cient in some tissues and can vary according to develop-
mental stage and species (Belles, 2010). For instance,
injection of dsRNA in D. melanogaster larvae does not trig-
ger RNAi in most tissues except the haemocytes (Miller
et al., 2008). It is possible that the RNAi machinery is not
highly expressed in some tissues, as observed in An. gam-
biae salivary glands (Boisson et al., 2006), and this may
affect the silencing efficiency of transcripts according to
the tissues in which they are expressed. However, studies
in D. melanogaster highly suggest that the poor efficiency
of RNAi in some tissues is rather due to a low penetration
of dsRNA (Miller et al., 2008). Similarly, contrary to midgut
cells and ovaries, salivary glands could not uptake siRNAs
in An. gambiae, suggesting that this tissue could also be
more resistant to dsRNA uptake, consistent with the
requirement to inject high quantity of dsRNA to achieve
gene silencing in this tissue (Boisson et al., 2006).We have
previously shown that p400 is highly expressed in ovaries
and p400 protein is highly detected in tracheae as well as
in the germline cells within the germarium (McFarlane
et al., 2020). Therefore, it is possible that silencing in those
particular cells may be more difficult to achieve due to a
weak dsRNA uptake, even in presence of liposomes. As
some dsRNAses can be expressed in a tissue-specific
manner and limit RNAi efficiency in Ae. aegypti larvae
(Giesbrecht et al., 2020), it is also possible that genes
difficult to knockdown are expressed in adult female tis-
sues expressing dsRNAses.
The difficulty to observe a satisfying silencing four days
post dsRNA injection for genes such as p400 and E75
could also be linked to efficient feedback mechanisms reg-
ulating gene expression. As a consequence, it would
reduce the long-lasting effect of gene silencing as
observed inBlatella germanicawhen targeting a lipophorin
receptor (Ciudad et al., 2007) and also in Ae. aegyptiwhen
targeting Cactus (Raquin et al., 2017). It would thus be
interesting to analyse transcript expression levels of tar-
geted genes at earlier and later time points post dsRNA
injection to assess whether silencing efficiency could
change over time.
Finally, the ability of siRNA to silence genes in Ae.
aegypti females was studied because if demonstrated to
be effective, siRNA-induced silencing could prove to be a
more time- and cost-effectivemethod of transient silencing.
Unfortunately, in our hands the siRNA targeting ago2, even
when injected along with a transfection reagent, did not
silence their target in vivo while it did in vitro. Our results
contrast with reports of successful gene silencing using
siRNA injection in Ae. aegypti pupal brain (Tomchaney
et al., 2014) and embryos (Clemons et al., 2011). Absence
of silencing using siRNA was also shown in T. castaneum
(Miller et al., 2012) and the nematode Caenorhabditis ele-
gans. As previously observed in T. castaneum (Miller
et al., 2012) and in An. gambiae salivary glands (Boisson
et al., 2006; Miller et al., 2012), there may be a tissue per-
meability issue where the shorter dsRNAs/siRNAs are not
taken up by the target tissues. This would explain why siR-
NAs can efficiently silence genes in embryos (injection of
siRNAs before cellularization) or in pupae (destruction of
larval tissues, formation of adult ones and transformation
of larval to adult tissues). Alternatively, the lack of silencing
could be due to the degradation of the siRNAs by stage-
and/or tissue-specific RNAses. Loss of nucleotides from
the siRNA would impact recognition and/or uptake by
Ago2 and therefore the siRNA pathway would not be
activated.
Transient knockdown of target transcripts is an important
method of investigating gene function. In this study, we
found that transient knockdown using siRNA was not pos-
sible in adult mosquitoes. While for some targets, success-
ful and significant knockdown can be achieved using
dsRNA, some others can be harder to silence. In case, a
dsRNA injected at a classical concentration (e.g. 500 ng)
does not result in a satisfying silencing efficiency, we pro-
pose a set of guidelines to improve silencing efficiency.
First, a second dsRNA should be designed and further
tested. Second, higher doses, up to 2 μg per female should
be tested. Finally, a cationic transfection reagent can be
added to enhance knockdown through reduction in varia-
tion between replicates. Although transient gene silencing
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by RNAi is not tissue-specific nor permanent compared to
genome editing, until genetic tools and reagents are devel-
oped with the same ease and availability as for
D. melanogaster, this technique remains the easier and
faster option for identification and functional characteriza-
tion of mosquito genes. This technique is particularly
advantageous to screen many genes for their involvement
in arbovirus infection in mosquitoes. Therefore, these
guidelines will benefit such analyses to increase our knowl-
edge of mosquito-arbovirus interactions.
4. Experimental Procedures
4.1 Mosquito rearing
Ae. aegypti Liverpool strain (a gift from E. Devaney, Uni-
versity of Glasgow, UK) was reared at 28C and 80%
humidity with a 12:12 light photoperiod. Larvaewere reared
in water and fed on dry cat food from larvae hatching to the
pupal stage. The emerging adult mosquitoes were trans-
ferred in cages with unlimited access to 10% weight/vol
sucrose solution. Female mosquitoes were fed on hepari-
nised rabbit blood (Orygen Antibodies Ltd) using a Hemo-
tek system (Hemotek Ltd, UK).
4.2 Cell culture
Ae. aegypti-derived Aag2 cells (a kind gift of P. Eggleston,
Keele University, UK) were maintained in Leibowitz L-15
medium supplemented with 10% fetal bovine serum
(FBS, Gibco), 10% tryptose phosphate broth (TPB, Gibco)
and penicillin–streptomycin (Gibco). Mosquito cells were
maintained at 28 C.
4.3 dsRNA design, synthesis and purification for
mosquito injection
Total RNA was extracted with TRIzol (Thermo Fisher Sci-
entific) from whole NBF Ae. aegypti females according to
manufacturer’s instructions with 1-bromo-3-chloropropane
(Sigma) in place of chloroform and including DNase treat-
ment (TURBO DNase, Ambion). cDNA was generated
from 1 μg of total RNA using MMLV retro-transcriptase
(Thermoscientific) and random hexamers pDN6
(Invitrogen). cDNA was used for production of the dsRNAs
targeting p400, E75 and ago2 genes and the plasmid tem-
plate Drosophilaact5C-βGal (Stock number 1220 obtained
from DGRC) was used for dsLacZ (used as control
dsRNA). dsRNA were produced as previously described
(McFarlane et al., 2020) using gene-specific primers with
T7 RNA polymerase promoter sequence (Table S1).
dsp400-1, dsago2, dsE75-1 and dsE75-2 (both targeting
all E75 isoforms) were designed using the E-RNAi webser-
vice (https://www.dkfz.de/signaling/e-rnai3/0) and to
roughly have the same size to exclude size effect.
dsp400-2 was designed previously (McFarlane
et al., 2020).
4.4 siRNA design, production and preparation
The siRNA targeting ago2 (siago2) was designed based on
the previous study in Ae. aegypti-derived cell line (Varjak
et al., 2017). The siRNA targeting βGal (siLacZ, used as
control) was designed by Dharmacon (# D-
002000-01-20). Sequences of siRNAs can be found in
Table S2. siRNAs were produced and purified for either
standard or in vivo application (Dharmacon). siRNA for
standard application were provided as desalted duplex
ready to use after resuspension. siRNA for in vivo applica-
tion were processed by counter-ion (Na+) exchange,
desalted, filtered sterilely and tested for endotoxin. siRNAs
were resuspended in nuclease-free PBS or water following
Dharmacon’s instructions, aliquoted and stored at −20 C.
4.5 Sequencing
To check that the siago2 sequence matched the Ae.
aegypti Liverpool strain used in this study, cDNA from
whole Ae. aegypti females was used to amplify the corre-
sponding gene region by PCR using KOD HOT Start mas-
ter mix (Sigma) and specific primers (Table S1). The PCR
fragment was gel purified using QIAquick gel extraction
kit (Qiagen) and ligated in pJET plasmid (Thermo Scien-
tific) and transformed in JM109 competent bacteria
(Promega). Transformed bacteria were cultured overnight
in LB media supplemented with ampicillin. Plasmid DNA
was extracted from colonies using QIAquick miniprep kit
(Qiagen). Sequencing of the insert was performed by
Source Bioscience. Sequence matching with the siRNA
sequence was analysed on Serial Cloner software v2.6.1.
4.6 dsRNA and siRNA injection in mosquitoes and
sampling
At 1–2 days after emergence, cold-anesthetized female
mosquitoes (n = 15–20 per condition and replicate) were
injected using a nanoinjector (Nanoject II, Drummond Sci-
entific). Cellfectin® II (Thermofisher) or DharmaFECT2
(Horizon Discovery) transfection reagent was mixed with
S2 medium (Life Technologies) (1:1, vol:vol). After 5 min
of incubation, this mix was added to dsRNA/siRNA solution
(1:1, vol:vol) previously adjusted with S2 medium to give
the required quantity of dsRNA/siRNA per female/injection
volume. The injection solution was then incubated for
15 min at room temperature before injection. For conditions
without transfection reagent, the dsRNA solution was
adjusted with S2 medium to give the required quantity of
dsRNA/siRNA per female/injection volume. After injection,
mosquitoes were left to recover in netted cardboard boxes
with cotton balls wet with 10% sucrose. To decrease bacte-
rial infection risk post-injection, injected mosquitoes were
362 M. McFarlane et al.
© 2021 The Authors. Insect Molecular Biology published by John Wiley & Sons Ltd on behalf of Royal Entomological Society, 30, 355–365
left at 21 C and 80% of humidity for 24 h and then moved
to 28 C and 80% of humidity. Four days post-injection,
10 mosquitoes were homogenized in 1 ml of TRIzol
reagent (Thermo Fisher Scientific) with glass beads using
the Precellys 24 homogenizer (Bertin Instruments) before
RNA extraction.
4.7 Analysis of mosquito survival
The effect of injection with different reagents on mosquito
survival was studied by injecting 40–50 mosquitoes per
condition and replicate. The same final volume (414 nl)
was injected for all conditions. When using dsRNA or
siRNA, the same quantity (2 μg) was also injected for all
conditions. Survival was monitored for 3 days by counting
and removing by aspiration dead mosquitoes.
4.8 Cell transfection and sampling
1.7 × 105 Aag2 cells were plated out in 24 well plates. The
following morning, LacZ and ago2 targeting siRNAs (5 ng/μl
final) were transfected into the Aag2 cells using Dharma-
fect2 (HorizonDiscovery) according tomanufacturer’s proto-
col. siRNA-treated cells were sampled 1 day after
transfection. Cells were centrifuged at 4 C and 400×g for
10 min. Cell media were then replaced with 1 ml of TRIzol
(Thermo Fisher Scientific) for further RNA extraction.
4.9 RNA extraction and reverse-transcription
Total RNA from siRNA-treated cells and whole females
was extracted with TRIzol (Thermo Fisher Scientific) fol-
lowing manufacturer’s instructions with 1-bromo-
3-chloropropane (Sigma) in place of chloroform and a
DNAse treatment (TURBO DNase kit, Ambion). cDNA
was generated from 1 μg of total RNA in 40 μl through
reverse-transcription (RT) using the MMLV Reverse Tran-
scriptase (Thermoscientific) and random hexamers pDN6
(Invitrogen) according to manufacturer’s protocol. For each
sample, 3 independent RTs (further pooled) and 1 negative
reverse-transcription control (NRT) were prepared. The
NRT includes all reagents except the reverse-transcriptase
which was replaced by water. cDNAs were stored at
−20 C into 2.8 μl aliquots for further qPCR analysis.
4.10 qPCR analysis
qPCR was performed using 2.8 μl cDNA aliquots with
FAST SYBR Green master mix (Applied Biosystems)
according to manufacturer’s instructions and using the
7500 Fast PCR Machine (Applied Biosystems). Primers
used to check the knock down efficiency were designed
to be outside of the dsRNA regions to avoid dsRNA ampli-
fication and are listed in Table S1. Results were treated
with the 7500 Software v2.0.6 and analysed as described
previously (Taylor et al., 2019). The ribosomal S7 transcript
was used as reference to normalized expression values,
and dsLacZ control group geomean was set at 1. The RQ
minimum and maximum were calculated from the geo-
mean and displayed as error bars. For each experiment,
data were obtained from 3 biological replicates and
10 females pooled per condition and replicate.
4.11 Statistical analysis
Statistical analysis was conducted using Graph Pad v7.02
software. Mosquito survival analyses were conducted with
a survival curve and Log-rank Mantel-Cox test. Analysis of
qPCR data was conducted using unpaired and two-tailed t-
tests on Log2-normalized expression values according to
Taylor’s method (Taylor et al., 2019).
Acknowledgements
We would like to thank Joy Kean for mosquito rearing and
training with procedures. This work was funded by the UK
Medical Research Council (MC_UU_12014/8) to A.K. and
E.P.
Author Contributions
M.M: Data curation, Formal Analysis, Investigation, Meth-
odology, Supervision, Validation Visualization, Writing –
original draft, Writing – review & editing. M.L: Data curation,
Formal Analysis, Investigation, Methodology, Validation,
Writing – original draft, Writing – review & editing. T.L: Data
curation, Formal Analysis, Investigation, Validation. S.T:
Resources. A.K: Funding acquisition, Writing- review &
editing. E.P: Conceptualization, Data curation, Formal
Analysis, Funding acquisition, Methodology, Project
administration, Supervision, Validation, Writing – original
draft, Writing – review & editing.
Conflicts of Interest
The authors declare no conflict of interest.
Data Availability
The datasets generated and analysed during the current
study are available in the University of Glasgow repository
(https://doi.org/10.5525/gla.researchdata.1082).
References
Achee, N.L., Grieco, J.P., Vatandoost, H., Seixas, G., Pinto, J.,
Ching-Ng, L. et al. (2019) Alternative strategies for mosquito-
borne arbovirus control. PLoS Neglected Tropical Diseases,
13, e0006822.
Anglero-Rodriguez, Y.I., Macleod, H.J., Kang, S., Carlson, J.S.,
Jupatanakul, N. and Dimopoulos, G. (2017) Aedes aegypti
Molecular Responses to Zika Virus: Modulation of Infection
by the Toll and Jak/Stat Immune Pathways and Virus Host Fac-
tors. Frontiers in Microbiology, 8, 2050.
Transient gene silencing in Aedes aegypti 363
© 2021 The Authors. Insect Molecular Biology published by John Wiley & Sons Ltd on behalf of Royal Entomological Society, 30, 355–365
Barletta, A.B., Nascimento-Silva, M.C., Talyuli, O.A., Oliveira, J.H.,
Pereira, L.O., Oliveira, P.L. et al. (2017) Microbiota activates
IMD pathway and limits Sindbis infection in Aedes aegypti.
Parasites & Vectors, 10, 103.
Belles, X. (2010) Beyond Drosophila: RNAi in vivo and functional
genomics in insects. Annual Review of Entomology,
55, 111–128.
Blair, C.D. and Olson, K.E. (2015) The role of RNA interference
(RNAi) in arbovirus-vector interactions. Viruses, 7, 820–843.
Blandin, S., Moita, L.F., Kocher, T., Wilm, M., Kafatos, F.C. and
Levashina, E.A. (2002) Reverse genetics in the mosquito
Anopheles gambiae: targeted disruption of the Defensin gene.
EMBO Reports, 3, 852–856.
Boisson, B., Jacques, J.C., Choumet, V., Martin, E., Xu, J.,
Vernick, K. et al. (2006) Gene silencing in mosquito salivary
glands by RNAi. FEBS Letters, 580, 1988–1992.
Carissimo, G., Pondeville, E., Mcfarlane, M., Dietrich, I., Mitri, C.,
Bischoff, E. et al. (2015) Antiviral immunity of Anopheles gam-
biae is highly compartmentalized, with distinct roles for RNA
interference and gut microbiota. Proceedings of the National
Academy of Sciences of the United States of America, 112,
E176–E185.
Chaverra-Rodriguez, D., Macias, V.M., Hughes, G.L., Pujhari, S.,
Suzuki, Y., Peterson, D.R. et al. (2018) Targeted delivery of
CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for her-
itable germline gene editing.Nature Communications, 9, 3008.
Cheng, G., Liu, L., Wang, P., Zhang, Y., Zhao, Y.O., Colpitts, T.M.
et al. (2011) An in vivo transfection approach elucidates a role
for Aedes aegypti thioester-containing proteins in flaviviral
infection. PLoS One, 6, e22786.
Ciudad, L., Belles, X. and Piulachs, M.D. (2007) Structural and
RNAi characterization of the German cockroach lipophorin
receptor, and the evolutionary relationships of lipoprotein
receptors. BMC Molecular Biology, 8, 53.
Clemons, A., Haugen, M., Le, C., Mori, A., Tomchaney, M.,
Severson, D.W. et al. (2011) siRNA-mediated gene targeting
in Aedes aegypti embryos reveals that frazzled regulates vec-
tor mosquito CNS development. PLoS One, 6, e16730.
Cruz, J., Mane-Padros, D., Zou, Z. and Raikhel, A.S. (2012) Distinct
roles of isoforms of the heme-liganded nuclear receptor E75, an
insect ortholog of the vertebrate Rev-erb, in mosquito reproduc-
tion.Molecular and Cellular Endocrinology, 349, 262–271.
Dietzl, G., Chen, D., Schnorrer, F., Su, K.C., Barinova, Y.,
Fellner, M. et al. (2007) A genome-wide transgenic RNAi library
for conditional gene inactivation in Drosophila. Nature, 448,
151–156.
Donald, C.L., Kohl, A. and Schnettler, E. (2012) New Insights into
Control of Arbovirus Replication and Spread by Insect RNA
Interference Pathways. Insects, 3, 511–531.
Dusfour, I., Vontas, J., David, J.P., Weetman, D., Fonseca, D.M.,
Corbel, V. et al. (2019) Management of insecticide resistance
in the major Aedes vectors of arboviruses: Advances and chal-
lenges. PLoS Neglected Tropical Diseases, 13, e0007615.
Garbutt, J.S., Belles, X., Richards, E.H. and Reynolds, S.E. (2013)
Persistence of double-stranded RNA in insect hemolymph as a
potential determiner of RNA interference success: evidence
fromManduca sexta andBlattella germanica. Journal of Insect
Physiology, 59, 171–178.
Giesbrecht, D., Heschuk, D., Wiens, I., Boguski, D., Lachance, P.
and Whyard, S. (2020) RNA Interference Is Enhanced by
Knockdown of double-stranded RNases in the Yellow Fever
Mosquito Aedes aegypti. Insects, 11, 327.
Horn, T. and Boutros, M. (2010) E-RNAi: a web application for the
multi-species design of RNAi reagents—2010 update. Nucleic
Acids Research, 38, W332–W339.
Joga, M.R., Zotti, M.J., Smagghe, G. and Christiaens, O. (2016)
RNAi efficiency, systemic properties, and novel delivery
methods for pest insect control: what we know so far. Frontiers
in Physiology, 7, 553.
Kean, J., Rainey, S.M., Mcfarlane, M., Donald, C.L., Schnettler, E.,
Kohl, A. et al. (2015) Fighting arbovirus transmission: natural
and engineered control of vector competence in Aedes mos-
quitoes. Insects, 6, 236–278.
Kistler, K.E., Vosshall, L.B. and Matthews, B.J. (2015) Genome
engineering with CRISPR-Cas9 in the mosquito Aedes
aegypti. Cell Reports, 11, 51–60.
Kulkarni, M.M., Booker, M., Silver, S.J., Friedman, A., Hong, P.,
Perrimon, N. et al. (2006) Evidence of off-target effects associ-
ated with long dsRNAs in Drosophila melanogaster cell-based
assays. Nature Methods, 3, 833–838.
Lambrechts, L. and Saleh, M.C. (2019)ManipulatingMosquito Tol-
erance for Arbovirus Control. Cell Host & Microbe,
26, 309–313.
Li, M., Bui, M., Yang, T., Bowman, C.S., White, B.J. and Akbari, O.
S. (2017) Germline Cas9 expression yields highly efficient
genome engineering in a major worldwide disease vector,
Aedes aegypti. Proceedings of the National Academy of Sci-
ences of the United States of America, 114, E10540–E10549.
Mayer, S.V., Tesh, R.B. and Vasilakis, N. (2017) The emergence
of arthropod-borne viral diseases: A global prospective on den-
gue, chikungunya and zika fevers. Acta Tropica, 166,
155–163.
McFarlane, M., Almire, F., Kean, J., Donald, C.L.,
Mcdonald, A., Wee, B. et al. (2020) The Aedes aegypti
Domino Ortholog p400 Regulates Antiviral Exogenous
Small Interfering RNA Pathway Activity and ago-2 Expres-
sion. mSphere, 5(2).
McFarlane, M., Arias-Goeta, C., Martin, E., O’hara, Z., Lulla, A.,
Mousson, L. et al. (2014) Characterization of Aedes aegypti
innate-immune pathways that limit Chikungunya virus replica-
tion. PLoS Neglected Tropical Diseases, 8, e2994.
Meredith, J.M., Basu, S., Nimmo, D.D., Larget-Thiery, I., Warr, E.
L., Underhill, A. et al. (2011) Site-specific integration and
expression of an anti-malarial gene in transgenic Anopheles
gambiae significantly reduces Plasmodium infections. PLoS
One, 6, e14587.
Miller, S.C., Brown, S.J. and Tomoyasu, Y. (2008) Larval RNAi in
Drosophila? Development Genes and Evolution, 218,
505–510.
Miller, S.C., Miyata, K., Brown, S.J. and Tomoyasu, Y. (2012) Dis-
secting systemic RNA interference in the red flour beetle Tribo-
lium castaneum: parameters affecting the efficiency of RNAi.
PLoS One, 7, e47431.
Mito, T., Nakamura, T., Bando, T., Ohuchi, H. and Noji, S. (2011)
The advent of RNA interference in Entomology. Entomological
Science, 14, 1–8.
364 M. McFarlane et al.
© 2021 The Authors. Insect Molecular Biology published by John Wiley & Sons Ltd on behalf of Royal Entomological Society, 30, 355–365
Nimmo, D.D., Alphey, L., Meredith, J.M. and Eggleston, P. (2006)
High efficiency site-specific genetic engineering of the mos-
quito genome. Insect Molecular Biology, 15, 129–136.
Osta, M.A., Christophides, G.K. andKafatos, F.C. (2004) Effects of
mosquito genes on Plasmodium development. Science, 303,
2030–2032.
Paixao, E.S., Teixeira, M.G. and Rodrigues, L.C. (2018) Zika, chi-
kungunya and dengue: the causes and threats of new and re-
emerging arboviral diseases. BMJ Global Health, 3, e000530.
Pondeville, E., Puchot, N., Meredith, J.M., Lynd, A., Vernick, K.D.,
Lycett, G.J. et al. (2014) Efficient PhiC31 integrase-mediated
site-specific germline transformation of Anopheles gambiae.
Nature Protocols, 9, 1698–1712.
Raquin, V., Merkling, S.H., Gausson, V., Moltini-Conclois, I.,
Frangeul, L., Varet, H. et al. (2017) Individual co-variation
between viral RNA load and gene expression reveals novel host
factors during early dengue virus infection of the Aedes aegypti
midgut. PLoS Neglected Tropical Diseases, 11, e0006152.
Samuel, G.H., Adelman, Z.N. and Myles, K.M. (2018) Antiviral
immunity and virus-mediated antagonism in disease vector
mosquitoes. Trends in Microbiology, 26, 447–461.
Shukla, J.N., Kalsi, M., Sethi, A., Narva, K.E., Fishilevich, E.,
Singh, S. et al. (2016) Reduced stability and intracellular trans-
port of dsRNA contribute to poor RNAi response in lepidop-
teran insects. RNA Biology, 13, 656–669.
Sim, S., Jupatanakul, N., Ramirez, J.L., Kang, S., Romero-
Vivas, C.M., Mohammed, H. et al. (2013) Transcriptomic profil-
ing of diverse Aedes aegypti strains reveals increased
basal-level immune activation in dengue virus-refractory popu-
lations and identifies novel virus-vector molecular interactions.
PLoS Neglected Tropical Diseases, 7, e2295.
Taylor, S.C., Nadeau, K., Abbasi, M., Lachance, C., Nguyen, M.
and Fenrich, J. (2019) The ultimate qPCR experiment: produc-
ing publication quality, reproducible data the first time. Trends
in Biotechnology, 37, 761–774.
Tomchaney, M., Mysore, K., Sun, L., Li, P., Emrich, S.J.,
Severson, D.W. et al. (2014) Examination of the genetic basis
for sexual dimorphism in the Aedes aegypti (dengue vector
mosquito) pupal brain. Biology of Sex Differences, 5, 10.
Varjak, M., Maringer, K., Watson, M., Sreenu, V.B., Fredericks, A.
C., Pondeville, E. et al. (2017) Aedes aegypti Piwi4 is a nonca-
nonical PIWI protein involved in antiviral responses.
mSphere, 2.
Vermeulen, A., Behlen, L., Reynolds, A., Wolfson, A., Marshall, W.
S., Karpilow, J. et al. (2005) The contributions of dsRNA struc-
ture to Dicer specificity and efficiency. RNA, 11, 674–682.
Wang, K., Peng, Y., Pu, J., Fu, W., Wang, J. and Han, Z. (2016)
Variation in RNAi efficacy among insect species is attributable
to dsRNA degradation in vivo. Insect Biochemistry andMolec-
ular Biology, 77, 1–9.
Weaver, S.C., Costa, F., Garcia-Blanco, M.A., Ko, A.I., Ribeiro, G.
S., Saade, G. et al. (2016) Zika virus: History, emergence, biol-
ogy, and prospects for control. Antiviral Research, 130, 69–80.
Weaver, S.C. and Reisen, W.K. (2010) Present and future arbo-
viral threats. Antiviral Research, 85, 328–345.
Wilder-Smith, A., Gubler, D.J., Weaver, S.C., Monath, T.P.,
Heymann, D.L. and Scott, T.W. (2017) Epidemic arboviral dis-
eases: priorities for research and public health. The Lancet
Infectious Diseases, 17, e101–e106.
Supporting Information
Additional supporting information may be found online in
the Supporting Information section at the end of the
article.
Figure S1: Analysis of female survival. (A) Female mosquito survival for
4 days after injection of either siRNA lacZ purified for standard or in vivo
application or PBS. Survivals were not significantly different using a Log-
rankMantel-Cox test. (B) Femalemosquito survival for 4 days after injection
of either PBS or nuclease free water. Survivals were not significantly differ-
ent using a Log-rank Mantel-Cox test.
Table S1: Primers used for dsRNA synthesis, to check knockdown effi-
ciency and to sequence ago2 region targeted by siago2.
Table S2: siRNA sequences and position within target gene.
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